CCN020 Ovaprene
Brief description of study
The Ovaprene® Contraceptive is a monthly nonhormonal intravaginal contraceptive indicated for the prevention of pregnancy in women of reproductive age. This single arm open-label study intends to enroll approximately 656 sexually active women at risk for pregnancy to conduct the pivotol effectiveness study. Participants will use Ovaprene as their sole method of contraception, completing regular follow-up visits, for approximately 13 menstrual cycles.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
